ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2018 ACR/ARHP Annual Meeting

October 19-24, 2018. Chicago, IL.

View by Number View by Title View Sessions
View by Date

Monday, October 22, 2018

9:00AM-11:00AM
Abstract Number: 1185
Cause and Rate of Hospitalization of Lupus Patients
Health Services Research Poster II – ACR/ARHP
9:00AM-11:00AM
Abstract Number: 1140
Cause-Specific Mortality in Knee, Hip and Hand Osteoarthritis
Epidemiology and Public Health Poster II: Gout, Ankylosing Spondylitis, Osteoarthritis, Osteoporosis, Pain, and Function
9:00AM-11:00AM
Abstract Number: 1111
CBS004, a Novel Monoclonal Antibody Against Bdca-2 Inhibits TLR-Induced Activation of Human pDC in Vitro and In Vivo. a Novel Therapeutic Target for Systemic Sclerosis
Systemic Sclerosis and Related Disorders – Basic Science Poster II
9:00AM-11:00AM
Abstract Number: 987
CCL11 Is Involved in Cell Migration in Rheumatoid Arthritis
Cytokines and Cell Trafficking Poster
9:00AM-11:00AM
Abstract Number: 1090
Cell-Free Mitochondrial DNA As a Novel Biomarker in Systemic Lupus Erythematosus
Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster II
9:00AM-11:00AM
Abstract Number: 1765
Cerebrospinal Fluid Biomarker of Disease Activity: Significance in ANCA-Related Hypertrophic Pachymeningitis
Vasculitis – ANCA-Associated Poster I
9:00AM-11:00AM
Abstract Number: 1688
Changes in Heart Rate Variability Reflect Clinical Improvement and Flare in Systemic Lupus Erythematosus
Systemic Lupus Erythematosus – Clinical Poster II: Biomarkers and Outcomes
9:00AM-11:00AM
Abstract Number: 1083
Changes of Innate Lymphoid Cells in Peripheral Blood of Patients with Systemic Lupus Erythematosus and Its Correlations with Clinical Markers
Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster II
9:00AM-11:00AM
Abstract Number: 1388
Characteristics and Symptom Severity in 21,101 Patients Reporting Systemic Lupus Erythematous in the Patientslikeme Online Health Community
Patient Outcomes, Preferences, and Attitudes Poster I: Patient-Reported Outcomes
9:00AM-11:00AM
Abstract Number: 1812
Characterization and Prevalence of Morbus Behçet in Switzerland
Vasculitis Poster II: Behҫet’s Disease and IgG4-Related Disease
9:00AM-11:00AM
Abstract Number: 1110
Characterization of CD20+ T Cells in Patients with Systemic Sclerosis
Systemic Sclerosis and Related Disorders – Basic Science Poster II
9:00AM-11:00AM
Abstract Number: 1117
Characterization of the Esophageal Microbiome in Patients with Systemic Sclerosis (SSc)
Systemic Sclerosis and Related Disorders – Basic Science Poster II
9:00AM-11:00AM
Abstract Number: 1068
Characterization of the Role of Endocannabinoid System Using Jwh-133, a Selective Cannabinoid CB2 Receptor Agonist, in IL-1β-Induced Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts
Rheumatoid Arthritis – Etiology and Pathogenesis Poster II
9:00AM-11:00AM
Abstract Number: 1215
Characterizing Changes in the Median Nerve during Hand Grip Using Dynamic Sonographic Imaging
Imaging of Rheumatic Diseases Poster II – ARHP
9:00AM-11:00AM
Abstract Number: 1763
Characterizing the Gut and Plasma Metabolomes in Patients with ANCA-Associated Vasculitis
Vasculitis – ANCA-Associated Poster I
  • «Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 65
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology